Affymax to Present at the BIO CEO & Investor Conference BIO CEO & Investor Conference 2013 Business Wire PALO ALTO, Calif. -- February 6, 2013 Affymax, Inc. (Nasdaq: AFFY) today announced that John Orwin, the company's chief executive officer, will present at the 15^th Annual BIO CEO & Investor Conference on Tuesday, February 12, 2013 at 9:30 a.m. Eastern Time (6:30 a.m. Pacific Time) in New York City. A live webcast of the presentation will be available on the investors section of the company's website at http://www.investors.affymax.com/events.cfm. A replay will also be available for 30 days following the presentation. About Affymax, Inc. Affymax, Inc. is a biopharmaceutical company based in Palo Alto, California. Affymax's mission is to discover, develop and deliver innovative therapies that improve the lives of patients with kidney disease and other serious and often life-threatening illnesses. The company's first marketed product, OMONTYS^® (peginesatide) Injection, was approved by the U.S. Food and Drug Administration (FDA) in March 2012. For additional information, please visit www.affymax.com. Contact: Affymax, Inc. Alexandra Santos, 650-812-8961 Associate Director, Corporate Communications
Affymax to Present at the BIO CEO & Investor Conference
Press spacebar to pause and continue. Press esc to stop.